Interview with CEO Axel Sjöblad (Q4 2017)

NewsFebruary 12, 2018

Axel Sjöblad, Managing Director of BioGaia AB, summarizes the fourth quarter of 2017 and answers the following questions:

  • Q4 was a record quarter with 23% sales growth. Can you comment on this development?
  • For the second quarter in a row Adult Health showed a significant increase in sales growth. Do you see any effects of inventory buildup or will we see the same rate growth going forward?
  • On an annual basis, sales increased by 15% while EBIT grew to 234 MSEK (199). What were you most satisfied with during the year? What are the priorities for 2018?
  • Despite an increase in dividend BioGaia has a strong financial position. Regarding acquisitions, are you mostly looking for new strains or companies?

Upcoming events

January 5, 2025

Invitation to media and analyst briefing for BioGaia

Elementum nisi pharetra faucibus cras. At massa pretium sodales nunc arcu ullamcorper semper.
January 15, 2025

BioGaia AB: Year-end report January – December 2023

Elementum nisi pharetra faucibus cras. At massa pretium sodales nunc arcu ullamcorper semper.

Subscribe to our press releases

Vulputate proin pellentesque ut tincidunt elementum volutpat urna dolor sit amet.

Subscribe